Tag: Biopharmaceuticals

It usually takes time for scientific discoveries in the lab to make their way to the market.The groundbreaking gene-editing technology ...

Amgen has a couple of shots on goal to break into one of the biggest markets the pharmaceutical industry has ...

Pentwater Capital predicted that FTC efforts to block big deals would fail.

VinFast, the Vietnamese electric-vehicle maker, and Arm, a British chip designer, are caught in a weird limbo thanks to their ...

Roivant, started by presidential candidate Vivek Ramaswamy, could seal a deal in coming days.

The potential FDA approval of BioMarin’s gene therapy for hemophilia A would be a major win, but patient uptake could ...

Coherus BioSciences’ partnership to offer deeply discounted biosimilar Humira can go only so far in reducing overall prices.

Merck & Co. is in late-stage talks to acquire Prometheus Biosciences Inc., according to people familiar with the matter, a ...

The drugmaker recently had a market value almost $18 billion as big pharmaceutical companies rely on acquisitions to expand sales.

MarketsHeard on the StreetAs AbbVie’s Humira faces copycat biologics, the biggest beneficiaries will be the middlemen negotiating and dispensing the ...